Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma

Biology of Blood and Marrow Transplantation

Volumn 2, Issue 2, 1996, Pages 76-85

  Stockerl Goldstein, Keith E ^a,b   Horning, Sandra J ^a   Negrin, Robert S ^a   Chao, Nelson J ^a   Hu, Wendy W ^a   Long, Gwynn D ^a   Hoppe, Richard T ^b   Amylon, Michael D ^b   Brown Jr , Byron W ^b   Wong, Ruby M ^b   Blume, Karl G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Non Hodgkin's lymphoma; Peripheral blood progenitor cells

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; CHILD; COMPARATIVE STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0030133620     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parker S, Tong T, Bolden S, Wingo P: Cancer Statistics, 1996. CA 46:5, 1996.
2. Rabkin CS, Devesa SS, Zahm SH, Gail MH: Increasing incidence of non-Hodgkin's lymphoma. Semin Hematol 30:286, 1993.
3. De Vita VT, Canellos GP, Chabner B, Schein P, Hubbard SP, Young RC: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1:248, 1975.
4. Fisher RI, Gaynor ER, Dablberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002, 1993.
5. Gordon LI, Harrington D, Andersen J, Colgan J, Glich J, Neiman R, Mann R, Resnick GD, Barcos M, Gottlieb A, O'Connell M: Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327:1342, 1992.
6. Cabanillas F: Experience with salvage regimens at AI.D. Anderson Hospital. Ann Oncol 2 (Suppl 1):31, 1991.
7. Nowrousian MR, Anders CH, Niederle N, Nagel-Hiemke M, Moritz T, Seeker S, Schmidt CG: Etoposide, ifosfamide, and methotrexate with or without bleomycin inrefractory or recurrent lymphomas. Ann Oncol 2 (Suppl 1):25, 1991.
8. Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F, Barlogie B: Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71:117, 1988.
9. Velasquez WS, McLaugblin P, Tucker S, hagemeister FB, Swan F, Rodrignez MA, Romaguera J, Rubenstein E, Cabanillas F: ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12:1169, 1994.
10. Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, Chabner BA: EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 11:1573, 1993.
11. Appelbaum FR, Sullivan KM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Hill R, Mortimer J, Neiman PE, Sanders JE, Singer J, Stewart P, Storb R, Thomas ED: Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol 5:1340, 1987.
12. Colombat P, Gorin NC, Lemonnier MP, Binet C, Laporte JP, Douay L, Desbois I, Lofez M, Lamagnere JP, Najman A: The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphoma. J Clin Oncol 8:630, 1990.
13. Gulati S, Yabalom J, Acaba L, Reich L, Motzer R, Crown J, Tola M, Igarasbi T, Lemoli R, Hanninen E, Doherty M: Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. J Clin Oncol 10:936, 1992.
14. Horning SJ, Negrin RS, Chao NJ, Long GD, Hoppe RT, Blume KG: Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol 12:2552, 1994.
15. Mills W, Chopra R, McMillan A, Pearce R, Limb DC, Goldstone AH: BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 13:588, 1995.
16. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cabn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laport JP, Maranincbi D, Pica J, Bosly A, Anderson C, Schots R, Biron P, Cabanillas F, Dicke K: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493, 1987.
17. Verdonck LF, Dekker AW, de Gast GC, van Kaufen ML, Lokborst HM, Nieuwenhuis HK: Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP. J Clin Oncol 10:1949, 1992.
18. Wheeler C, Strawderman M, Ayash L, Churchill WH, Bierer BE, Elias A, Gilliland DG, Antman K, Guinan EC, Eder JP, Weinstein H, Schwartz G, Ferrara J, Mazanet R, Rimm IJ, Tepler I, McCarthy P, Mauch P, Ault K, Gaynes L, McCauley M, Schnipper LE, Antin J: Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide. J Clin Oncol 11:1085, 1993.
19. Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinove SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Roberfson MJ, Blake K, Coral F, Canellos GP, Ritz J, Nadler LM: Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J Clin Oncol 11:931, 1993.
20. Lazarus HM, Crilley P, Ciobannu N, Creger RJ, Fox RM, Shina DC, Bttlova SI, Gcalp R, Cooper BW, Topolsky D, Soegiarso W, Brodsky I: High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 10:1682, 1992.
21. Philip T, Gaglielmi C, Hagenbeek A, Somers R, Van derLelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffer B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540, 1995.
22. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112, 1982.
23. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987, 1993.
24. Chao NJ, Nadamance AP, Long GD, Schmidt GM, Donlon TA, Parker P, Slovak ML, Nagasawa LS, Blume KG, Forman SJ: Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. J Clin Oncol 9:1575, 1991.
25. Jin NR, Hill RS, Petersen FB, Buckner CD, Stewart PS, Amos D, Appelbaum FR, Clift RA, Bensinger WI, Sanders JE, Doney KC, Sullivan KM, Witherspoon RP, Deeg HJ, Storb R, Livingston R, Chard R, Thomas ED: Marrow harvesting for autologous marrow transplantation. Exp Hematol 13:879, 1985.
26. Negrin RS, Pesando J: Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J Clin Oncol 12:1021, 1994.
27. Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Homing SJ, Brown BW, Blume KG, Strober S: Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 85:3334, 1995.
28. O'Donnell MR, Schmidt GM, Tegtmeier BR, Faucett C, Fahey JL, Ito J, Nademanee A, Niland J, Parker P, Smith EP, Snyder ES, Stein AS, Blimie KG, Forman SJ: Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827, 1994.
29. Advani R, Chao NJ, Homing SJ, Blume KG, Abu DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL: Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med 116:183, 1992.
30. Attal M, Hugtiet F, Rubie H, Huynb A, Charlet JP, Payen JL, Voigt JJ, Brousset P, Selves J, Millier C, Pris J, Laurent G: Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 79:2834, 1992.
31. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 135:185, 1958.
32. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966.
33. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972.
34. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993.
35. Goldstone AH, Singer CRJ, Gribben JG, Jarret M: Fifth report of EBMTG experience of ABMT in malignant lymphoma. Bone Marrow Transplant 3:33, 1988.
36. Rapoport AP, Rove JM, Kouides PA, Duerst RA, Abbond CN, Liesveld JL, Packman CH, Eberly S, Sberman M, Tanner MA, Constine LS, DiPersio JF: One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. J Clin Oncol 11:2351, 1993.
37. Petersen FB, Appelbaum FR, Hill R, Fisher LD, Bigelov CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP, Storb R, Clift RA, Fefer A, Press OW, Weiden PL, Singer J, Thomas ED, Blickner CD: Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. J Clin Oncol 8:638, 1990.
38. Vase JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage JO: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846, 1993.
39. Meeban KR, Pritcbard RS, Leichter JW, Littenberg B, Welch HG: Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature. Am J Hematol 50:116, 1995.